TCT 687: Combined DeepOCT+NIRS Imaging for Coronary Stent Optimization: Results from the Investigational Study of SpectraWAVE’s HyperVue Imaging System

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Philips; Novo Nordisk; Xenter; ACIST Medical; Shockwave Medical; Amgen; Gentuity; Terumo Medical Corporation</li></ul>